Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion type Assertion NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_head.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion wasGeneratedBy ECO_0000203 NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion wasDerivedFrom befree-2016 NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion SIO_000772 10545285 NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion evidence source_evidence_literature NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.
- NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266665.RAdkWFbN_7WW5LgT59alz6eI8iNzPy_pBD17vQPCtUws4130_provenance.